Cr Medisystems Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-07-2024
- Paid Up Capital ₹ 0.46 M
as on 30-07-2024
- Company Age 49 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 61.71 M
as on 30-07-2024
- Revenue 18.21%
(FY 2023)
- Profit 69.52%
(FY 2023)
- Ebitda 83.40%
(FY 2023)
- Net Worth 25.13%
(FY 2023)
- Total Assets 13.99%
(FY 2023)
About Cr Medisystems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.46 M.
The company currently has active open charges totaling ₹6.17 Cr.
Chandru Thadhani, Vinay Thadani, Kiran Ramdurgkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100MH1974PTC018007
- Company No.
018007
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 1974
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cr Medisystems Private Limited offer?
Cr Medisystems Private Limited offers a wide range of products and services, including Medical Equipment & Accessories, Nurse Call System, Hospital and Medical Furniture, Hospital Equipment, Curtain and Drapery Hardware, Curtain Tracks, Forceps & Graspers, Surgical Pendant, Hospital Furniture, Hospital & Medical Lights.
Who are the key members and board of directors at Cr Medisystems?
Board Members(4)
Financial Performance and Corporate Structure Insights of Cr Medisystems.
Cr Medisystems Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.21% increase. The company also saw a substantial improvement in profitability, with a 69.52% increase in profit. The company's net worth Soared by an impressive increase of 25.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cr Medisystems?
In 2023, Cr Medisystems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Sep 2020 | ₹1.40 Cr | Open |
Indian Overseas Bank Creation Date: 26 Feb 2018 | ₹1.86 Cr | Open |
Solapur Janata Sahakari Bank Ltd Creation Date: 09 Sep 2015 | ₹2.00 Cr | Open |
How Many Employees Work at Cr Medisystems?
Unlock and access historical data on people associated with Cr Medisystems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cr Medisystems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cr Medisystems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
